Wegovy Pill Side Effects: What to Expect & How to Manage Them

Key Takeaways

Nausea (~47%), vomiting (~31%), constipation (~20%), and diarrhea (~18%) are the most common Wegovy tablet side effects, peaking after dose step-ups.
Only 6.9% of trial participants discontinued oral semaglutide due to side effects — slow 30-day titration lets digestion adapt.
Smaller low-fat meals, steady hydration, and staying upright after eating ease symptoms; severe radiating abdominal pain requires urgent medical evaluation.

Starting the Wegovy pill (oral semaglutide) brings the same GLP-1 appetite regulation as weekly injections — and because semaglutide slows gastric emptying so food stays in your stomach longer, temporary digestive side effects are common while your gut adapts (1–3).

Common vs. uncommon oral semaglutide side effects

In the Phase 3 OASIS-4 study, 74% of participants reported at least one gastrointestinal symptom, yet only 6.9% stopped treatment due to side effects because most episodes were mild to moderate and transient (1):

Very common (>1 in 10): Nausea, vomiting, diarrhea, constipation, abdominal discomfort, headache, and mild fatigue (1,3).
Common (up to 1 in 10): Indigestion, burping, dizziness, temporary hair shedding (related to rapid weight loss), and mild skin tingling (3).
Uncommon (up to 1 in 100): Slight resting heart-rate increase or low blood pressure.

Six practical habits that settle GLP-1 nausea

Eat smaller, protein-forward mini-meals rather than large portions.
Skip greasy, fried, or heavily spiced foods, especially in the week after stepping up a dose.
Eat slowly and pause at the first sign of comfortable fullness.
Sip water or electrolyte fluids steadily throughout the day (starting 30+ minutes after your morning pill).
Remain upright for 30–60 minutes after eating to prevent reflux.
Hold at your current strength longer with your clinician’s guidance if symptoms haven’t settled after 30 days.

Rare serious symptoms requiring urgent medical care

Seek immediate medical attention for severe, persistent upper abdominal pain radiating to your back (possible pancreatitis), fever or yellowing of skin/eyes (gallbladder disease), or facial/throat swelling (allergy). Oral semaglutide is also contraindicated in anyone with a personal or family history of medullary thyroid carcinoma or MEN2 (3). Discuss personalized GLP-1 dosing with a clinician via our online intake.

References

Wharton S, Lingvay I, et al. Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity. N Engl J Med. 2025;393(11):1077–87.
Novo Nordisk. Wegovy (semaglutide) tablets — U.S. patient information. 2026.
Novo Nordisk. Wegovy (semaglutide) tablets 25 mg — U.S. prescribing information. 2026.

Medical Editorial Review: Reviewed by the Amble Clinical Editorial Team. This article is for educational purposes only and does not replace an individualized consultation with a licensed healthcare professional.

Related Clinical Guides

GLP-1 & Weight Loss · 9 minComparing Mounjaro Costs by Dose: What Full-Year Treatment Actually CostsMounjaro costs scale across six strengths from 2.5mg to 15mg — meaning provider choice, included supplies, and maintenance dosing can create more than a $750 annual difference.GLP-1 & Weight Loss · 6 minWhat Is the 'Golden Dose' of Mounjaro — and Why You Shouldn't Use ItSocial media posts often call the priming liquid left inside a Mounjaro pen after four injections the 'golden 5th dose.' Here is why extracting it risks inaccurate dosing and contamination.GLP-1 & Weight Loss · 6 minOrforglipron (Foundayo) Cost Guide: What Daily GLP-1 Tablets CostFoundayo (orforglipron) offers needle-free GLP-1 weight loss in a once-daily small-molecule tablet. Explore how tablet strengths, titration packs, and clinical care shape monthly pricing.

Your personalizedweight care plan

Clinician-prescribed GLP-1 & metabolic care, 100% online.

Get started